Home Newsfeeds Synlogic Granted U.S. Patent Titled ‘BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION (INCLUDING BUT NOT LIMITED TO CELIAC DISEASE, CROHN’S DISEASE, MULTIPLE SCLEROSIS)’

Synlogic Granted U.S. Patent Titled ‘BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION (INCLUDING BUT NOT LIMITED TO CELIAC DISEASE, CROHN’S DISEASE, MULTIPLE SCLEROSIS)’

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11384359&OS=11384359&RS=11384359

byBenzinga Newsdesk

July 12, 2022

1 minute read

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11384359&OS=11384359&RS=11384359

Why Is Intel Stock Moving Higher Wednesday?

By Anusuya Lahiri

February 14, 2:47 PM

Intel Corp (NASDAQ: INTC) seeks $2B in equity for Irish plant. Brookfield invested $15B in Arizona expansion. Intel plans to launch Gaudi 3 AI accelerator in 2024.

AMD

Innovative Eyewear Shares Are Tumbling: What’s Going On?

By Adam Eckert

June 22, 9:59 AM

Innovative Eyewear Inc (NASDAQ: LUCY) shares are trading lower Thursday after the company announced the pricing of a public offering.

LUCY

News

NIMS Selects Ansys’ Materials Solution To Advance More Sustainable Next-Gen Jet Engines

By Benzinga Newsdesk

June 15, 9:13 AM

Japan's sole public research organization adopts Ansys' materials data management solution to develop an eco-friendly materials catalog for efficient aircraft engine development/ Key HighlightsNIMS is using Ansys'

ANSS

News

IAA Continues To Invest Strategically In North American Footprint

By Happy Mohamed

April 27, 8:37 AM

Flexible real estate strategy provides capacity when and where it is needed most IAA Holdings, LLC (IAA), a Ritchie Bros. Auctioneers Incorporated company (NYSE:RBA) (TSX:RBA) and trusted global marketplace for

RBA

Synlogic Granted U.S. Patent Titled ‘BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION (INCLUDING BUT NOT LIMITED TO CELIAC DISEASE, CROHN’S DISEASE, MULTIPLE SCLEROSIS)’

Related Posts

Why Is Intel Stock Moving Higher Wednesday?

Innovative Eyewear Shares Are Tumbling: What’s Going On?

NIMS Selects Ansys’ Materials Solution To Advance More Sustainable Next-Gen Jet Engines

IAA Continues To Invest Strategically In North American Footprint